Recruiting Ankylosing Spondylitis Studies in Roma
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894)....
Open-Label Extension of EryDex Study IEDAT-04-2022
This is an international, multi-center, prospective, open-label, non-comparative study to provide EryDex treatment to ataxia telangiectasia (A-T) patients who complete the IEDAT-04-2022 trial on the n...
About Ankylosing Spondylitis Clinical Trials in Roma
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Roma, . These studies are seeking a combined 256 participants. Research is being sponsored by Crinetics Pharmaceuticals Inc., Quince Therapeutics S.p.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Roma — FAQ
Are there ankylosing spondylitis clinical trials in Roma?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Roma, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Roma?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Roma research site will contact you about next steps.
Are clinical trials in Roma free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Roma studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Roma are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov